Variant report
Variant | nsv8260 |
---|---|
Chromosome Location | chr8:1338368-1356817 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139267775 | chr8:1338375-1338376 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551613490 | chr8:1338391-1338392 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571797397 | chr8:1338398-1338399 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527919869 | chr8:1338421-1338422 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369601358 | chr8:1338435-1338436 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185114933 | chr8:1338436-1338437 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542727158 | chr8:1338441-1338442 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149635825 | chr8:1338464-1338465 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536215992 | chr8:1338478-1338479 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377671192 | chr8:1338504-1338505 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149115001 | chr8:1338508-1338509 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369520217 | chr8:1338510-1338511 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561207272 | chr8:1338535-1338536 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531331176 | chr8:1338578-1338579 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189521512 | chr8:1338584-1338585 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569624102 | chr8:1338596-1338597 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538708646 | chr8:1338602-1338603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35628917 | chr8:1338618-1338619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558407980 | chr8:1338641-1338642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs873854 | chr8:1338642-1338643 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs74452547 | chr8:1338644-1338645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182186227 | chr8:1338647-1338648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375308734 | chr8:1338679-1338680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs367898835 | chr8:1338700-1338701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542582294 | chr8:1338710-1338711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188132941 | chr8:1338727-1338728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576394698 | chr8:1338730-1338731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144398519 | chr8:1338745-1338746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565283947 | chr8:1338751-1338752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17754782 | chr8:1338752-1338753 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs563539721 | chr8:1338764-1338765 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548022499 | chr8:1338805-1338806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561532431 | chr8:1338811-1338812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530441393 | chr8:1338829-1338830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191354750 | chr8:1338837-1338838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117925924 | chr8:1338849-1338850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548277834 | chr8:1338860-1338861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552200913 | chr8:1338904-1338905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148762072 | chr8:1338916-1338917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534476195 | chr8:1338940-1338941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554363898 | chr8:1338974-1338975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574319861 | chr8:1338976-1338977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74929282 | chr8:1338979-1338980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557015230 | chr8:1338980-1338981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs757885 | chr8:1338986-1338987 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs545076939 | chr8:1338990-1338991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142404443 | chr8:1339011-1339012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565342223 | chr8:1339026-1339027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs367667857 | chr8:1339039-1339040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6997319 | chr8:1339072-1339073 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Cancer | 18840272 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Autism | 20531469 | CNVD |
Breast cancer | 20932292 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:1336400-1338800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr8:1337200-1338600 | Bivalent Enhancer | Fetal Stomach | stomach |
3 | chr8:1337600-1339000 | Enhancers | Fetal Brain Male | brain |
4 | chr8:1337800-1338600 | Enhancers | Fetal Brain Female | brain |
5 | chr8:1338000-1340400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:1340400-1340600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr8:1340400-1340600 | Enhancers | Stomach Smooth Muscle | stomach |
8 | chr8:1356000-1356800 | ZNF genes & repeats | Esophagus | oesophagus |
9 | chr8:1356600-1357200 | Enhancers | Brain Germinal Matrix | brain |